Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Streamex Corp. Director's Dealing 2023

Feb 8, 2023

35540_dirs_2023-02-08_7d14e9d6-c630-4e9c-a781-29b7bc2b171b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioSig Technologies, Inc. (BSGM)
CIK: 0001530766
Period of Report: 2023-02-08

Reporting Person: BUHALY STEVEN J (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-02-08 Common Stock P 232882 Acquired 232882 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-02-08 Warrants (right to buy) $0.7963 P 116441 Acquired 2028-08-08 Common Stock (116441) Direct

Footnotes

F1: The combined purchase price for a share of common stock and the accompanying warrant to purchase 0.5 of a share was $0.8588.